Joseph Burnett

1.1k total citations
26 papers, 879 citations indexed

About

Joseph Burnett is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Joseph Burnett has authored 26 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 7 papers in Biomedical Engineering. Recurrent topics in Joseph Burnett's work include Cancer Cells and Metastasis (8 papers), Nanoplatforms for cancer theranostics (6 papers) and Peptidase Inhibition and Analysis (5 papers). Joseph Burnett is often cited by papers focused on Cancer Cells and Metastasis (8 papers), Nanoplatforms for cancer theranostics (6 papers) and Peptidase Inhibition and Analysis (5 papers). Joseph Burnett collaborates with scholars based in United States, China and Georgia. Joseph Burnett's co-authors include Duxin Sun, Hayley J. Paholak, Lichao Sun, Hongwei Chen, Yuliang Ran, Hebao Yuan, Max S. Wicha, Xin Luan, Fuxiang Zhang and Jiaming Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Biomaterials and Cancer Research.

In The Last Decade

Joseph Burnett

25 papers receiving 876 citations

Peers

Joseph Burnett
Hayley J. Paholak United States
Krishnendu Pal United States
Meghna Mehta United States
Yawen Guo China
Zheng Han China
Xiuquan Luo United States
Ling Bai China
Batoul Farran United States
Hayley J. Paholak United States
Joseph Burnett
Citations per year, relative to Joseph Burnett Joseph Burnett (= 1×) peers Hayley J. Paholak

Countries citing papers authored by Joseph Burnett

Since Specialization
Citations

This map shows the geographic impact of Joseph Burnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Burnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Burnett more than expected).

Fields of papers citing papers by Joseph Burnett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Burnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Burnett. The network helps show where Joseph Burnett may publish in the future.

Co-authorship network of co-authors of Joseph Burnett

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Burnett. A scholar is included among the top collaborators of Joseph Burnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Burnett. Joseph Burnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luan, Xin, Hebao Yuan, Yudong Song, et al.. (2021). Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation. Biomaterials. 275. 120910–120910. 53 indexed citations
2.
Wang, Yipeng, Yibin Xie, Yanan Niu, et al.. (2021). Carboxypeptidase A4 negatively correlates with p53 expression and regulates the stemness of breast cancer cells. International Journal of Medical Sciences. 18(8). 1753–1759. 10 indexed citations
3.
Sun, Lichao, Hebao Yuan, Joseph Burnett, et al.. (2018). MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer. International Journal of Medical Sciences. 16(1). 68–74. 15 indexed citations
4.
Luo, Ming, Michael Brooks, Joseph Burnett, et al.. (2018). Abstract LB-053: Tracing redox-regulated breast cancer stem cell state transition using a dual fluorescent reporter system. Cancer Research. 78(13_Supplement). LB–53.
5.
Sun, Lichao, Chunguang Guo, Jianzhong Cao, et al.. (2017). Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer. International Journal of Medical Sciences. 14(7). 655–661. 28 indexed citations
6.
Burnett, Joseph, Yanyan Li, Hayley J. Paholak, et al.. (2017). Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells. Cancer Letters. 394. 52–64. 115 indexed citations
7.
Sun, Lichao, Jianzhong Cao, Changyuan Guo, et al.. (2017). Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma. Diseases of the Esophagus. 30(6). 1–5. 16 indexed citations
8.
Sun, Lichao, Hebao Yuan, Joseph Burnett, et al.. (2016). CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer. Journal of Cancer. 7(10). 1197–1204. 31 indexed citations
9.
Paholak, Hayley J., Nicholas Stevers, Hongwei Chen, et al.. (2016). Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy. Biomaterials. 104. 145–157. 44 indexed citations
10.
Sun, Lichao, Chunguang Guo, Joseph Burnett, et al.. (2016). Association between expression of Carboxypeptidase 4 and stem cell markers and their clinical significance in liver cancer development. Journal of Cancer. 8(1). 111–116. 16 indexed citations
11.
Sun, Lichao, Chunguang Guo, Joseph Burnett, et al.. (2016). Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma. Oncotarget. 7(48). 78688–78697. 12 indexed citations
12.
Sun, Lichao, Chunguang Guo, Hebao Yuan, et al.. (2016). Overexpression of carboxypeptidase A4 (CPA4) is associated with poor prognosis in patients with gastric cancer.. PubMed. 8(11). 5071–5075. 26 indexed citations
13.
Conley, Sarah J., Joseph Burnett, Douglas Lazarus, et al.. (2015). CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancer. Breast Cancer Research and Treatment. 150(3). 559–567. 55 indexed citations
14.
Burnett, Joseph, Hasan Körkaya, Maria Ouzounova, et al.. (2015). Trastuzumab resistance induces EMT to transform HER2+ PTEN− to a triple negative breast cancer that requires unique treatment options. Scientific Reports. 5(1). 15821–15821. 54 indexed citations
15.
Chen, Hongwei, Xiaoqing Ren, Hayley J. Paholak, et al.. (2015). Facile Fabrication of Near-Infrared-Resonant and Magnetic Resonance Imaging-Capable Nanomediators for Photothermal Therapy. ACS Applied Materials & Interfaces. 7(23). 12814–12823. 14 indexed citations
16.
Burnett, Joseph, Hasan Körkaya, Hui Jiang, et al.. (2014). Abstract 218: MEOX-1 as a novel cancer stem cell target for treatment of trastuzumab-resistant Her2+ breast cancers. Cancer Research. 74(19_Supplement). 218–218. 2 indexed citations
17.
Chen, Hongwei, Joseph Burnett, Fuxiang Zhang, et al.. (2013). Highly crystallized iron oxide nanoparticles as effective and biodegradable mediators for photothermal cancer therapy. Journal of Materials Chemistry B. 2(7). 757–765. 105 indexed citations
18.
Chen, Sung-Liang, Joseph Burnett, Duxin Sun, et al.. (2013). Photoacoustic microscopy: a potential new tool for evaluation of angiogenesis inhibitor. Biomedical Optics Express. 4(11). 2657–2657. 15 indexed citations
19.
Burnett, Joseph, Bryan Newman, & Duxin Sun. (2012). Targeting Cancer Stem Cells with Natural Products. Current Drug Targets. 13(8). 1054–1064. 27 indexed citations
20.
Jiang, Yiqun, Denzil Bernard, Yanke Yu, et al.. (2010). Split Renilla Luciferase Protein Fragment-assisted Complementation (SRL-PFAC) to Characterize Hsp90-Cdc37 Complex and Identify Critical Residues in Protein/Protein Interactions. Journal of Biological Chemistry. 285(27). 21023–21036. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026